Literature DB >> 29733456

Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation.

Shida Yousefi1, Satish K Sharma2, Darko Stojkov1, Nina Germic1, Salome Aeschlimann1, Moyar Q Ge2,3, Cameron H Flayer3, Erik D Larson3, Imre G Redai2, Suhong Zhang2, Cynthia J Koziol-White2,4, Katalin Karikó2, Hans-Uwe Simon1, Angela Haczku2,3.   

Abstract

The asthmatic airways are highly susceptible to inflammatory injury by air pollutants such as ozone (O3 ), characterized by enhanced activation of eosinophilic granulocytes and a failure of immune protective mechanisms. Eosinophil activation during asthma exacerbation contributes to the proinflammatory oxidative stress by high levels of nitric oxide (NO) production and extracellular DNA release. Surfactant protein-D (SP-D), an epithelial cell product of the airways, is a critical immune regulatory molecule with a multimeric structure susceptible to oxidative modifications. Using recombinant proteins and confocal imaging, we demonstrate here that SP-D directly bound to the membrane and inhibited extracellular DNA trap formation by human and murine eosinophils in a concentration and carbohydrate-dependent manner. Combined allergic airway sensitization and O3 exposure heightened eosinophilia and nos2 mRNA (iNOS) activation in the lung tissue and S-nitrosylation related de-oligomerisation of SP-D in the airways. In vitro reproduction of the iNOS action led to similar effects on SP-D. Importantly, S-nitrosylation abolished the ability of SP-D to block extracellular DNA trap formation. Thus, the homeostatic negative regulatory feedback between SP-D and eosinophils is destroyed by the NO-rich oxidative lung tissue environment in asthma exacerbations. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  eosinophil extracellular traps (EETs); eosinophils; surfactant pulmonary-associated protein D (SP-D)

Mesh:

Substances:

Year:  2018        PMID: 29733456      PMCID: PMC6450398          DOI: 10.1002/JLB.3AB1117-455R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  53 in total

Review 1.  Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.

Authors:  Shigeharu Ueki; Takahiro Tokunaga; Shigeharu Fujieda; Kohei Honda; Makoto Hirokawa; Lisa A Spencer; Peter F Weller
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

2.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

Authors:  Katalin Karikó; Hiromi Muramatsu; Frank A Welsh; János Ludwig; Hiroki Kato; Shizuo Akira; Drew Weissman
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

3.  Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways.

Authors:  Ryszard Dworski; Hans-Uwe Simon; Aimee Hoskins; Shida Yousefi
Journal:  J Allergy Clin Immunol       Date:  2011-02-18       Impact factor: 10.793

Review 4.  Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.

Authors:  Swati Agrawal; Robert G Townley
Journal:  Expert Opin Biol Ther       Date:  2013-11-28       Impact factor: 4.388

5.  Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice.

Authors:  Qi Yang; Moyar Q Ge; Blerina Kokalari; Imre G Redai; Xinxin Wang; David M Kemeny; Avinash Bhandoola; Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2015-08-15       Impact factor: 10.793

6.  Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo.

Authors:  Sadis Matalon; Kedar Shrestha; Marion Kirk; Stephanie Waldheuser; Barbara McDonald; Kelly Smith; Zhiqian Gao; Abderrazzak Belaaouaj; Erika C Crouch
Journal:  FASEB J       Date:  2009-01-06       Impact factor: 5.191

7.  Human surfactant protein D alters oxidative stress and HMGA1 expression to induce p53 apoptotic pathway in eosinophil leukemic cell line.

Authors:  Lakshna Mahajan; Hrishikesh Pandit; Taruna Madan; Poonam Gautam; Ajit K Yadav; Himangi Warke; Curam S Sundaram; Ravi Sirdeshmukh; P Usha Sarma; Uday Kishore; Avadhesha Surolia
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Surfactant protein D attenuates sub-epithelial fibrosis in allergic airways disease through TGF-β.

Authors:  Hirohisa Ogawa; Julie G Ledford; Sambuddho Mukherjee; Yoshinori Aono; Yasuhiko Nishioka; James J Lee; Keisuke Izumi; John W Hollingsworth
Journal:  Respir Res       Date:  2014-11-29

9.  Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.

Authors:  Neil E Alexis; John C Lay; Angela Haczku; Henry Gong; William Linn; Milan J Hazucha; Brad Harris; Ruth Tal-Singer; David B Peden
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

10.  Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study.

Authors:  Michael W Sims; Ruth M Tal-Singer; Sonja Kierstein; Ali I Musani; Michael F Beers; Reynold A Panettieri; Angela Haczku
Journal:  Respir Res       Date:  2008-01-28
View more
  13 in total

1.  Eosinophil cytolysis on Immunoglobulin G is associated with microtubule formation and suppression of rho-associated protein kinase signalling.

Authors:  Stephane Esnault; Jonathan P Leet; Mats W Johansson; Karina T Barretto; Paul S Fichtinger; Frances J Fogerty; Ksenija Bernau; Sameer K Mathur; Deane F Mosher; Nathan Sandbo; Nizar N Jarjour
Journal:  Clin Exp Allergy       Date:  2019-12-09       Impact factor: 5.018

2.  Ozone-induced enhancement of airway hyperreactivity in rhesus macaques: Effects of antioxidant treatment.

Authors:  Cameron H Flayer; Erik D Larson; Anjali Joseph; Sean Kao; Wenxiu Qu; Austin Van Haren; Christopher M Royer; Lisa A Miller; John P Capitanio; Thais Sielecki; Melpo Christofidou-Solomidou; Angela Haczku
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

Review 3.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Acute Respiratory Barrier Disruption by Ozone Exposure in Mice.

Authors:  Milena Sokolowska; Valerie F J Quesniaux; Cezmi A Akdis; Kian Fan Chung; Bernhard Ryffel; Dieudonnée Togbe
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

5.  Ozone Inhalation Attenuated the Effects of Budesonide on Aspergillus fumigatus-Induced Airway Inflammation and Hyperreactivity in Mice.

Authors:  Cameron H Flayer; Moyar Q Ge; Jin W Hwang; Blerina Kokalari; Imre G Redai; Zhilong Jiang; Angela Haczku
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

Review 6.  In vivo evidence for extracellular DNA trap formation.

Authors:  Shida Yousefi; Dagmar Simon; Darko Stojkov; Antonina Karsonova; Alexander Karaulov; Hans-Uwe Simon
Journal:  Cell Death Dis       Date:  2020-04-30       Impact factor: 8.469

Review 7.  Eosinophil responses during COVID-19 infections and coronavirus vaccination.

Authors:  Andrew W Lindsley; Justin T Schwartz; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2020-04-25       Impact factor: 10.793

Review 8.  SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.

Authors:  Alastair Watson; Jens Madsen; Howard William Clark
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

Review 9.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

Review 10.  Pulmonary Surfactants: a New Therapeutic Target in Asthma.

Authors:  Youngwoo Choi; Jaehyuk Jang; Hae-Sim Park
Journal:  Curr Allergy Asthma Rep       Date:  2020-09-11       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.